Jacobio Pharmaceuticals (01167) Announces Share Repurchase and Updated Share Capital

Bulletin Express11-13

Jacobio Pharmaceuticals Group Co., Ltd. (Stock code: 01167) disclosed that on 13 November 2025, 72,000 ordinary shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 6.92 to HKD 6.93 per share, for a total consideration of HKD 498,348. The repurchased shares are held as treasury shares.

After the transaction, Jacobio Pharmaceuticals holds 787,062,780 issued shares (excluding treasury shares) and 4,692,300 treasury shares, maintaining a total of 791,755,080 issued shares. The repurchase was conducted under an existing mandate approved on 10 June 2025, which authorized the company to repurchase up to 78,873,528 shares. So far, 1,672,500 shares (representing approximately 0.21205% of the issued shares at the time of the mandate) have been repurchased under this authorization.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment